Harvard Bioscience's Price Target Surges by 200% to $6.12 per Share

Harvard Bioscience's (HBIO) average one-year price target has been increased to $6.12/share, a 200% rise from the prior estimate of $2.04/share. The price target represents a 20.71% increase from the latest closing price of $5.07/share. There are 71 funds or institutions reporting positions in HBIO, with an average portfolio weight of 0.07%. The put/call ratio of HBIO is 0.07, indicating a bullish outlook.